期刊首页 优先出版 当期阅读 过刊浏览 作者中心 关于期刊 English

2008年 第2卷 第2期

摘要

关键词

相关研究

回顶部

《医学前沿（英文）》 >> 2008年 第2卷 第2期 doi: 10.1007/s11684-008-0022-1

Development and clinical trial of a novel bioactive bone cement

1.The Open University of Hong Kong；Department of Orthopaedics and Traumatology, The University of Hong Kong; 2.Department of Orthopaedics and Traumatology, The University of Hong Kong

发布日期： 2008-06-05
HTML21 PDF 3 收藏 0

下一篇 上一篇

摘要

Strontium (Sr) and related compounds have become more attractive in the prevention and treatment of osteoporosis. Previously, we developed a novel bioactive bone cement which is mainly composed of strontium-containing hydroxyapatite (Sr-HA) filler and bisphenol A diglycidylether dimethacrylate (Bis-GMA) resin. This bone cement is superior to conventional polymethylmethacrylate (PMMA) bone cement in bioactivity, biocompatibility, and osseointegration. It also has shown sufficient mechanical strength properties for its use in percutaneous vertebroplasty (PVP) and total hip replacement (THR). In this paper, we review the and clinical evidence for the effectiveness of this bioactive bone cement.

相关研究